EGLN1/c-Myc directly activates the expression of lymphoid-specific helicase (LSH) by inhibiting HIF-1α, then LSH as an oncogene epigenetically increases the expression level of lipid metabolic genes that inhibit ferroptosis in lung cancer (183). The gene discussed is HELLS; the disease is lung carcinoma.